RBM15B and diffuse large B-cell lymphoma: Six out of the 19 m6A regulators (ALKBH5, FMR1, HNRNPC, RBM15B, YTHDC2, and YTHDF1) showed statistically prognostic value in DLBCL patients (Figure 4(a)).